Pinterest Inc vs Repligen Corporation Common Stock — how do they compare? Pinterest Inc trades at $21.75 (market cap $12.32B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B). The key difference: Pinterest Inc and Repligen Corporation Common Stock are close in size by market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Pinterest Inc for 85 Days and Repligen Corporation Common Stock for 0 Days on average.
| PINS | RGEN | |
|---|---|---|
Market Cap | $12.32B | $11.31B |
Volume | 10,523,209 | 1,216,919 |
Sector | Media | Health |
52-Week High | $35.24 | $194.57 |
52-Week Low | $15.42 | $102.87 |
Typical Hold Time | 85 Days | 0 Days |
Enterprise Value | $12.24B | $11.20B |
Signals from Pluang's Aura AI — not financial advice
Pinterest (PINS) trades at $22.36, up 4.37% today, showing strong momentum after recent earnings beats. The stock maintains a bullish technical outlook with consistent revenue growth from $2.8B in 2022 to $4.2B in 2025. Analyst consensus is strongly positive with 54% buy ratings and a $27.93 price target, representing 25% upside potential. Recent news highlights Pinterest's visual search ads launch and international monetization growth as key catalysts.
The outlook remains favorable with strong fundamentals and technical momentum, though elevated valuation ratios (P/E 65.8) and insider selling present near-term risks. Revenue growth continues at 15%+ annually while profit margins improved from negative to 9.9% in 2025. Competition in digital advertising and market volatility are key watchpoints for investors.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →